Medplus Health Services Limited (MEDPLUS) - Total Liabilities

Latest as of March 2026: Rs19.58 Billion INR ≈ $211.74 Million USD

Based on the latest financial reports, Medplus Health Services Limited (MEDPLUS) has total liabilities worth Rs19.58 Billion INR (≈ $211.74 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check MEDPLUS asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Medplus Health Services Limited - Total Liabilities Trend (2019–2026)

This chart illustrates how Medplus Health Services Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Medplus Health Services Limited (MEDPLUS) total assets.

Medplus Health Services Limited Competitors by Total Liabilities

The table below lists competitors of Medplus Health Services Limited ranked by their total liabilities.

Company Country Total Liabilities
Savencia SA
PA:SAVE
France €2.94 Billion
CHINA RISUN GROUP HD-10
F:45Y
Germany €46.78 Billion
Fujian Boss Software Development Co Ltd
SHE:300525
China CN¥1.29 Billion
Beijing Join-Cheer Software Co Ltd
SHE:002279
China CN¥839.95 Million
Wanbangde Pharmaceutical Holding Group Co Ltd
SHE:002082
China CN¥1.86 Billion
Fujian Longxi Bearing Group Co Ltd
SHG:600592
China CN¥840.32 Million
Wuhan Zhongyuan Huadian Sci Tech
SHE:300018
China CN¥275.13 Million
Pet Valu Holdings Ltd
TO:PET
Canada CA$951.62 Million

Liability Composition Analysis (2019–2026)

This chart breaks down Medplus Health Services Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Medplus Health Services Limited to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.00 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.99 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.50 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medplus Health Services Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medplus Health Services Limited (2019–2026)

The table below shows the annual total liabilities of Medplus Health Services Limited from 2019 to 2026.

Year Total Liabilities Change
2026-03-31 Rs19.58 Billion
≈ $211.74 Million
+20.84%
2025-03-31 Rs16.20 Billion
≈ $175.22 Million
+13.50%
2024-03-31 Rs14.27 Billion
≈ $154.37 Million
+9.28%
2023-03-31 Rs13.06 Billion
≈ $141.26 Million
+11.00%
2022-03-31 Rs11.77 Billion
≈ $127.27 Million
+41.01%
2021-03-31 Rs8.35 Billion
≈ $90.25 Million
+1.83%
2020-03-31 Rs8.20 Billion
≈ $88.64 Million
+22.81%
2019-03-31 Rs6.67 Billion
≈ $72.17 Million
--

About Medplus Health Services Limited

NSE:MEDPLUS India Pharmaceutical Retailers
Market Cap
$856.68 Million
Rs79.21 Billion INR
Market Cap Rank
#9649 Global
#471 in India
Share Price
Rs659.65
Change (1 day)
+0.86%
52-Week Range
Rs649.30 - Rs953.90
All Time High
Rs1290.00
About

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more